What are the common side effects of furmonertinib, their occurrence time and countermeasures?

Furmonertinib (Furmonertinib) is an oral targeted drug for EGFR mutation-positive non-small cell lung cancer (NSCLC), and its efficacy has been verified in clinical trials. However, as a targeted drug, fumetinib also has certain side effects during treatment, which requires patients and clinicians to pay close attention. This article will provide a detailed analysis of common side effects, occurrence time, occurrence mechanism and countermeasures to help patients use this drug scientifically and safely.

First of all, one of the most common side effects of fumetinib is skin-related reactions, including rash, itching, dryness, and nail changes. Such side effects usually appear within the first 2 to 4 weeks after taking the medicine, and some patients may develop papular rashes on the face or chest and back. The mechanism is mainly related to the expression of EGFR in skin keratinocytes. When fumetinib inhibits the EGFR signaling pathway, skin cell proliferation and repair are affected. Response measures include using gentle skin care products, avoiding harsh cosmetics, and taking oral antihistamines or topical corticosteroid creams when necessary. For severe rashes, your doctor may recommend temporarily lowering your dose or interrupting your medication until symptoms subside before resuming.

Secondly, gastrointestinal reactions are also one of the common side effects of fumetinib, including diarrhea, nausea, vomiting, and loss of appetite. Most patients will develop these symptoms within 1 to 3 weeks of taking the medication, and some patients may last longer. The mechanism of occurrence is related to the regulatory effect of EGFR on intestinal epithelial cells. When drugs act on the intestine, they may affect the intestinal mucosal barrier function and secretion system, leading to indigestion. Coping strategies include eating a light diet, eating small amounts frequently, and avoiding greasy and irritating foods; use antidiarrheal or anti-nausea medications when necessary. Clinically, doctors will also adjust the dose of fumetinib according to the severity of symptoms to ensure a balance between efficacy and safety.

In addition, abnormal liver function is one of the side effects that needs to be paid attention to during the use of fumetinib, which is manifested by increased serum aminotransferases (ALT, AST), increased bilirubin, etc. This type of side effect usually appears about 1month after taking the medicine, but individual differences are large. Abnormal liver function is mainly due to certain effects on liver cells during drug metabolism. Patients should undergo basic liver function tests before taking the drug, and recheck every 4 to 6 weeks during treatment. If a mild increase occurs, observation and monitoring can continue; if a moderate or severe abnormality occurs, the drug needs to be temporarily discontinued or the dose adjusted, and liver-protective treatment should be taken under the guidance of a doctor.

Other side effects include fatigue, hypotension, heart palpitations, and interstitial lung disease. Fatigue usually occurs in the early stages of medication and can be improved through moderate rest, adjustment of work and rest, and nutritional support. Hypotension and palpitations are rare, but if they occur, you need to notify your doctor promptly and perform electrocardiogram and blood pressure monitoring. Although interstitial lung disease is rare, it is more harmful. If patients experience persistent cough, difficulty breathing or chest tightness, they should stop taking the medicine immediately and seek medical treatment.

To sum up, the side effects of fumetinib have a certain regularity, and most of them appear in the early stage of medication and can be managed through nursing care, drug assistance and dosage adjustment. Patients should maintain close communication with their doctors during the medication process, regularly monitor blood routine, liver function and cardiopulmonary function, and detect and deal with side effects in a timely manner to ensure the safety and efficacy of treatment. At the same time, through healthy lifestyle, dietary regulation and psychological support, patients can minimize the impact of side effects on their quality of life. The scientific and standardized use of fumetinib is the key to achieving long-term treatment effects and prolonging survival.

Reference materials:https://www.drugs.com/